chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dry eye, Fatigue, Headache
Clinical narrative: Worsening of dry eyes; Low energy; Fatigue upon exertion/felt fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (Worsening of dry eyes), ASTHENIA (Low energy), FATIGUE (Fatigue upon exertion/felt fatigue) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     Concurrent medical conditions included Sjogren's syndrome.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced DRY EYE (Worsening of dry eyes), ASTHENIA (Low energy), FATIGUE (Fatigue upon exertion/felt fatigue) and HEADACHE (Headache). At the time of the report, DRY EYE (Worsening of dry eyes), ASTHENIA (Low energy), FATIGUE (Fatigue upon exertion/felt fatigue) and HEADACHE (Headache) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Event outcome updated from unknown to recovering/resolving.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: He came to our pharmacy & the staff gave him another shot (2nd dose); This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He came to our pharmacy & the staff gave him another shot (2nd dose)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He came to our pharmacy & the staff gave him another shot (2nd dose)). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He came to our pharmacy & the staff gave him another shot (2nd dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  No treatment information was reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: fast heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heartbeat) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced HEART RATE INCREASED (fast heartbeat). At the time of the report, HEART RATE INCREASED (fast heartbeat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment drugs were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-103566 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103566:HUSBAND CASE
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Nausea, Presyncope, Product dose omission issue
Clinical narrative: Has not receive the 2nd dose (beyond day 35 after 1st dose); Back pain; Felt like he was going to collapse; Felt like he was going to vomit; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not receive the 2nd dose (beyond day 35 after 1st dose)), BACK PAIN (Back pain), PRESYNCOPE (Felt like he was going to collapse) and NAUSEA (Felt like he was going to vomit) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not receive the 2nd dose (beyond day 35 after 1st dose)), BACK PAIN (Back pain), PRESYNCOPE (Felt like he was going to collapse) and NAUSEA (Felt like he was going to vomit). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not receive the 2nd dose (beyond day 35 after 1st dose)), BACK PAIN (Back pain), PRESYNCOPE (Felt like he was going to collapse) and NAUSEA (Felt like he was going to vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No treatment information provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Dyspnoea, Erythema, Headache, Pruritus
Clinical narrative: Bad itching on the scalp; Trouble Breathing; Bad itching on back and neck; A lot of red spots on upper part of the body; Extremely dry skin on neck and back; dry skin on scalp; Headaches; Rash on the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body) and DRY SKIN (Extremely dry skin on neck and back) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body), DRY SKIN (Extremely dry skin on neck and back), DRY SKIN (dry skin on scalp), HEADACHE (Headaches) and VACCINATION SITE RASH (Rash on the arm at the injection site). At the time of the report, PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body), DRY SKIN (Extremely dry skin on neck and back), DRY SKIN (dry skin on scalp), HEADACHE (Headaches) and VACCINATION SITE RASH (Rash on the arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Bad itching on the scalp; Trouble Breathing; Bad itching on back and neck; A lot of red spots on upper part of the body; Extremely dry skin on neck and back; dry skin on scalp; Headaches; Rash on the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body) and DRY SKIN (Extremely dry skin on neck and back) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body), DRY SKIN (Extremely dry skin on neck and back), DRY SKIN (dry skin on scalp), HEADACHE (Headaches) and VACCINATION SITE RASH (Rash on the arm at the injection site). At the time of the report, PRURITUS (Bad itching on the scalp), DYSPNOEA (Trouble Breathing), PRURITUS (Bad itching on back and neck), ERYTHEMA (A lot of red spots on upper part of the body), DRY SKIN (Extremely dry skin on neck and back), DRY SKIN (dry skin on scalp), HEADACHE (Headaches) and VACCINATION SITE RASH (Rash on the arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia, Lymphadenopathy, Tenderness, Vaccination site erythema
Clinical narrative: Can't feel the lymph node; tender; lymph node swollen; fatigue; redness is getting down, but still there; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Can't feel the lymph node), TENDERNESS (tender), LYMPHADENOPATHY (lymph node swollen), FATIGUE (fatigue) and VACCINATION SITE ERYTHEMA (redness is getting down, but still there) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Can't feel the lymph node), TENDERNESS (tender), LYMPHADENOPATHY (lymph node swollen), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (redness is getting down, but still there) and VACCINATION SITE ERYTHEMA (redness around the injection site). At the time of the report, HYPOAESTHESIA (Can't feel the lymph node), TENDERNESS (tender), LYMPHADENOPATHY (lymph node swollen), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (redness is getting down, but still there) and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medications were  provided by Reporter. No Treatment was provided by Reporter.   Reporter did not allow further contact
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Myalgia, Pyrexia, Vaccination site erythema
Clinical narrative: warm arm; chills; redness at injection site; very itchy injection site; swollen arm at injection site; body ache; fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (warm arm), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE PRURITUS (very itchy injection site) and VACCINATION SITE SWELLING (swollen arm at injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (warm arm), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE PRURITUS (very itchy injection site), VACCINATION SITE SWELLING (swollen arm at injection site), MYALGIA (body ache) and PYREXIA (fever). At the time of the report, FEELING HOT (warm arm), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE PRURITUS (very itchy injection site), VACCINATION SITE SWELLING (swollen arm at injection site), MYALGIA (body ache) and PYREXIA (fever) outcome was unknown.            No concomitant medication information was provided. No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up information received on 20-Jul-2021 contains no new information.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: warm arm; chills; redness at injection site; very itchy injection site; swollen arm at injection site; body ache; fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (warm arm), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE PRURITUS (very itchy injection site) and VACCINATION SITE SWELLING (swollen arm at injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (warm arm), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE PRURITUS (very itchy injection site), VACCINATION SITE SWELLING (swollen arm at injection site), MYALGIA (body ache) and PYREXIA (fever). At the time of the report, FEELING HOT (warm arm), CHILLS (chills), VACCINATION SITE ERYTHEMA (redness at injection site), VACCINATION SITE PRURITUS (very itchy injection site), VACCINATION SITE SWELLING (swollen arm at injection site), MYALGIA (body ache) and PYREXIA (fever) outcome was unknown.            No concomitant medication information was provided. No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up information received on 20-Jul-2021 contains no new information.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Illness, Pyrexia
Clinical narrative: did feel ill; felt rather weak; had a temperature; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (did feel ill), ASTHENIA (felt rather weak) and PYREXIA (had a temperature) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (did feel ill), ASTHENIA (felt rather weak) and PYREXIA (had a temperature). At the time of the report, ILLNESS (did feel ill), ASTHENIA (felt rather weak) and PYREXIA (had a temperature) outcome was unknown. Not Provided          No Concomitant medications were provided No Treatment information provided    This case was linked to MODERNATX, INC.-MOD-2021-020644 (E2B Linked Report). This case was linked to MOD-2021-020644 (Patient Link).; Sender's Comments:  MODERNATX, INC.-MOD-2021-020644:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 02-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication: Benadryl and Tylenol No concomitant medication reported   This case was linked to MOD-2021-103524 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Breast pain, Chills, Fatigue, Pain
Clinical narrative: pain in left breast; worried/panicked about the breast pain; achy; chills; really tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BREAST PAIN (pain in left breast), ANXIETY (worried/panicked about the breast pain), PAIN (achy), CHILLS (chills) and FATIGUE (really tired) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 006B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Breast cancer. Concomitant products included VENLAFAXINE, ROSUVASTATIN and LEVOTHYROXINE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced PAIN (achy), CHILLS (chills) and FATIGUE (really tired). On an unknown date, the patient experienced BREAST PAIN (pain in left breast) and ANXIETY (worried/panicked about the breast pain). At the time of the report, BREAST PAIN (pain in left breast) and ANXIETY (worried/panicked about the breast pain) outcome was unknown and PAIN (achy), CHILLS (chills) and FATIGUE (really tired) had resolved.            Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to US-MODERNATX, INC.-MOD-2021-103585 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-103585:Case for dose 1
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Head discomfort, Vertigo
Clinical narrative: left side of head felt weird; room was spinning around; Chills; lightheadedness, could not control the head; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheadedness, could not control the head), HEAD DISCOMFORT (left side of head felt weird), VERTIGO (room was spinning around) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 010M20A) for COVID-19 vaccination.     No medical history was provided by the reported.  Concomitant products included BENAZEPRIL and NIFEDIPINE (NIFEDIPINE XL) for Blood pressure, PREGABALIN (LYRICA) for Fibromyalgia.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (lightheadedness, could not control the head) and CHILLS (Chills). On 23-Mar-2021, the patient experienced VERTIGO (room was spinning around). On 18-Apr-2021, the patient experienced HEAD DISCOMFORT (left side of head felt weird). On 11-Mar-2021, CHILLS (Chills) had resolved. On 11-Apr-2021, DIZZINESS (lightheadedness, could not control the head) had resolved. At the time of the report, HEAD DISCOMFORT (left side of head felt weird) and VERTIGO (room was spinning around) outcome was unknown.     Treatment information was included Steroid pack.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental exposure to product, Erythema, Pain
Clinical narrative: juice ran out of it when she stuck needle; brown spot; hurts; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT (juice ran out of it when she stuck needle), ERYTHEMA (brown spot) and PAIN (hurts) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT (juice ran out of it when she stuck needle), ERYTHEMA (brown spot) and PAIN (hurts). At the time of the report, ACCIDENTAL EXPOSURE TO PRODUCT (juice ran out of it when she stuck needle), ERYTHEMA (brown spot) and PAIN (hurts) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nasopharyngitis, Pyrexia
Clinical narrative: Sore arm / Body ache; Chills; cold; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm / Body ache), CHILLS (Chills), NASOPHARYNGITIS (cold), HEADACHE (headache) and PYREXIA (fever) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced MYALGIA (Sore arm / Body ache), CHILLS (Chills), NASOPHARYNGITIS (cold), HEADACHE (headache) and PYREXIA (fever). At the time of the report, MYALGIA (Sore arm / Body ache), CHILLS (Chills), NASOPHARYNGITIS (cold), HEADACHE (headache) and PYREXIA (fever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported   This case was linked to MOD-2021-103521 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Superficial vein prominence
Clinical narrative: veins poking out of tip of fingers; This spontaneous case was reported by a consumer and describes the occurrence of SUPERFICIAL VEIN PROMINENCE (veins poking out of tip of fingers) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced SUPERFICIAL VEIN PROMINENCE (veins poking out of tip of fingers). At the time of the report, SUPERFICIAL VEIN PROMINENCE (veins poking out of tip of fingers) outcome was unknown. Not Provided          No concomitant medications reported. No treatment information provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Dyspnoea, Hepatic pain, Neck pain
Clinical narrative: neck pain; shortness of breath; concerned about liver; hot burning sensation in middle of chest; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (hot burning sensation in middle of chest), NECK PAIN (neck pain), DYSPNOEA (shortness of breath) and HEPATIC PAIN (concerned about liver) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced CHEST PAIN (hot burning sensation in middle of chest). On 11-Apr-2021, the patient experienced NECK PAIN (neck pain), DYSPNOEA (shortness of breath) and HEPATIC PAIN (concerned about liver). At the time of the report, CHEST PAIN (hot burning sensation in middle of chest), NECK PAIN (neck pain), DYSPNOEA (shortness of breath) and HEPATIC PAIN (concerned about liver) outcome was unknown. Not Provided   Treatment information was provided i.e., Advil   DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, COVID-19: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue
Clinical narrative: did nt feel like eating; she is still feeling tired now; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (did nt feel like eating) and FATIGUE (she is still feeling tired now) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (did nt feel like eating) and FATIGUE (she is still feeling tired now). At the time of the report, DECREASED APPETITE (did nt feel like eating) and FATIGUE (she is still feeling tired now) outcome was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hair colour changes, Hair growth abnormal
Clinical narrative: the hair was completely white grey and now is starting to have black hair; started grow it's hair back / a new follicle on my bald area; This spontaneous case was reported by a consumer and describes the occurrence of HAIR COLOUR CHANGES (the hair was completely white grey and now is starting to have black hair) and HAIR GROWTH ABNORMAL (started grow it's hair back / a new follicle on my bald area) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HAIR COLOUR CHANGES (the hair was completely white grey and now is starting to have black hair) and HAIR GROWTH ABNORMAL (started grow it's hair back / a new follicle on my bald area). At the time of the report, HAIR COLOUR CHANGES (the hair was completely white grey and now is starting to have black hair) and HAIR GROWTH ABNORMAL (started grow it's hair back / a new follicle on my bald area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Information was not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol increased, Blood glucose increased
Clinical narrative: High Blood Sugar; High Blood Cholesterol after COVID-19 vaccination; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (High Blood Sugar) and BLOOD CHOLESTEROL INCREASED (High Blood Cholesterol after COVID-19 vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (High Blood Sugar) and BLOOD CHOLESTEROL INCREASED (High Blood Cholesterol after COVID-19 vaccination). At the time of the report, BLOOD GLUCOSE INCREASED (High Blood Sugar) and BLOOD CHOLESTEROL INCREASED (High Blood Cholesterol after COVID-19 vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-103362 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103362:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Diarrhoea, Eating disorder, Vaccination site pain
Clinical narrative: diarrhea, a worsening of the soreness on his left arm and a strong pain below the armpit of his left arm; diarrhea, a worsening of the soreness on his left arm and a strong pain below the armpit of his left arm; stopped eating; light soreness in the muscle of his left arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (diarrhea, a worsening of the soreness on his left arm and a strong pain below the armpit of his left arm), DIARRHOEA (diarrhea, a worsening of the soreness on his left arm and a strong pain below the armpit of his left arm), EATING DISORDER (stopped eating) and VACCINATION SITE PAIN (light soreness in the muscle of his left arm) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022c21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CHLOROPHYLL, MENTHA X PIPERITA (CHLOROPHYLL & MINT) for Hypertension, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced VACCINATION SITE PAIN (light soreness in the muscle of his left arm). On 04-May-2021, the patient experienced AXILLARY PAIN (diarrhea, a worsening of the soreness on his left arm and a strong pain below the armpit of his left arm), DIARRHOEA (diarrhea, a worsening of the soreness on his left arm and a strong pain below the armpit of his left arm) and EATING DISORDER (stopped eating). At the time of the report, AXILLARY PAIN (diarrhea, a worsening of the soreness on his left arm and a strong pain below the armpit of his left arm), DIARRHOEA (diarrhea, a worsening of the soreness on his left arm and a strong pain below the armpit of his left arm), EATING DISORDER (stopped eating) and VACCINATION SITE PAIN (light soreness in the muscle of his left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, Diarrhoea, Fear
Clinical narrative: loss of taste, prednisone tasted bad; loss of smell; diarrhea; Received 2nd dose 22 days after 1st dose; jerking and tingling 3 hours after receiving 2nd dose; Felt horrible, Brain fog; Was afraid; could not hold a glass of water; lethargic; back of my neck was hurting; sleeping for 20 hours a day; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose), PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose), FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid) and ASTHENIA (could not hold a glass of water) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Neuropathy, Ligament tear, Thyroid disorder, Autoimmune disorder and Hypertension. Concomitant products included PREDNISONE for Autoimmune disorder, ATENOLOL for Blood pressure high, GABAPENTIN (NEURONTIN) for Neuropathy, LIOTHYRONINE SODIUM (CYTOMEL) for Thyroid disorder.    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose), PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose), FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid), ASTHENIA (could not hold a glass of water), LETHARGY (lethargic), NECK PAIN (back of my neck was hurting) and SOMNOLENCE (sleeping for 20 hours a day). On an unknown date, the patient experienced AGEUSIA (loss of taste, prednisone tasted bad), ANOSMIA (loss of smell) and DIARRHOEA (diarrhea). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose) and NECK PAIN (back of my neck was hurting) had resolved, PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose) and LETHARGY (lethargic) had not resolved and FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid), ASTHENIA (could not hold a glass of water), SOMNOLENCE (sleeping for 20 hours a day), AGEUSIA (loss of taste, prednisone tasted bad), ANOSMIA (loss of smell) and DIARRHOEA (diarrhea) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information includes  Neurontin for 2 days   This case was linked to MOD-2021-071211 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Inappropriate schedule of product administration, Lethargy, Neck pain, Paraesthesia
Clinical narrative: loss of taste, prednisone tasted bad; loss of smell; diarrhea; Received 2nd dose 22 days after 1st dose; jerking and tingling 3 hours after receiving 2nd dose; Felt horrible, Brain fog; Was afraid; could not hold a glass of water; lethargic; back of my neck was hurting; sleeping for 20 hours a day; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose), PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose), FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid) and ASTHENIA (could not hold a glass of water) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Neuropathy, Ligament tear, Thyroid disorder, Autoimmune disorder and Hypertension. Concomitant products included PREDNISONE for Autoimmune disorder, ATENOLOL for Blood pressure high, GABAPENTIN (NEURONTIN) for Neuropathy, LIOTHYRONINE SODIUM (CYTOMEL) for Thyroid disorder.    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose), PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose), FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid), ASTHENIA (could not hold a glass of water), LETHARGY (lethargic), NECK PAIN (back of my neck was hurting) and SOMNOLENCE (sleeping for 20 hours a day). On an unknown date, the patient experienced AGEUSIA (loss of taste, prednisone tasted bad), ANOSMIA (loss of smell) and DIARRHOEA (diarrhea). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose) and NECK PAIN (back of my neck was hurting) had resolved, PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose) and LETHARGY (lethargic) had not resolved and FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid), ASTHENIA (could not hold a glass of water), SOMNOLENCE (sleeping for 20 hours a day), AGEUSIA (loss of taste, prednisone tasted bad), ANOSMIA (loss of smell) and DIARRHOEA (diarrhea) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information includes  Neurontin for 2 days   This case was linked to MOD-2021-071211 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: loss of taste, prednisone tasted bad; loss of smell; diarrhea; Received 2nd dose 22 days after 1st dose; jerking and tingling 3 hours after receiving 2nd dose; Felt horrible, Brain fog; Was afraid; could not hold a glass of water; lethargic; back of my neck was hurting; sleeping for 20 hours a day; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose), PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose), FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid) and ASTHENIA (could not hold a glass of water) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Neuropathy, Ligament tear, Thyroid disorder, Autoimmune disorder and Hypertension. Concomitant products included PREDNISONE for Autoimmune disorder, ATENOLOL for Blood pressure high, GABAPENTIN (NEURONTIN) for Neuropathy, LIOTHYRONINE SODIUM (CYTOMEL) for Thyroid disorder.    On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose), PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose), FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid), ASTHENIA (could not hold a glass of water), LETHARGY (lethargic), NECK PAIN (back of my neck was hurting) and SOMNOLENCE (sleeping for 20 hours a day). On an unknown date, the patient experienced AGEUSIA (loss of taste, prednisone tasted bad), ANOSMIA (loss of smell) and DIARRHOEA (diarrhea). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose 22 days after 1st dose) and NECK PAIN (back of my neck was hurting) had resolved, PARAESTHESIA (jerking and tingling 3 hours after receiving 2nd dose) and LETHARGY (lethargic) had not resolved and FEELING ABNORMAL (Felt horrible, Brain fog), FEAR (Was afraid), ASTHENIA (could not hold a glass of water), SOMNOLENCE (sleeping for 20 hours a day), AGEUSIA (loss of taste, prednisone tasted bad), ANOSMIA (loss of smell) and DIARRHOEA (diarrhea) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information includes  Neurontin for 2 days   This case was linked to MOD-2021-071211 (Patient Link).
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pyrexia, Somnolence
Clinical narrative: Sleeping alot; Feeling low; Fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleeping alot), MALAISE (Feeling low) and PYREXIA (Fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-1900, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced SOMNOLENCE (Sleeping alot), MALAISE (Feeling low) and PYREXIA (Fever). On 03-May-2021, PYREXIA (Fever) had resolved. At the time of the report, SOMNOLENCE (Sleeping alot) and MALAISE (Feeling low) outcome was unknown.            Concomitant medication was not provided Treatment medication include Tylenol .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient got the second dose in 3 weeks instead of 4 weeks apart; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient got the second dose in 3 weeks instead of 4 weeks apart) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient got the second dose in 3 weeks instead of 4 weeks apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient got the second dose in 3 weeks instead of 4 weeks apart) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Palpitations
Clinical narrative: Feeling dizzy; Heart racing; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Feeling dizzy), PALPITATIONS (Heart racing) and NAUSEA (Nausea) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced DIZZINESS (Feeling dizzy), PALPITATIONS (Heart racing) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Feeling dizzy), PALPITATIONS (Heart racing) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dysphagia, Headache, Hepatic enzyme increased, Hypertension
Clinical narrative: liver enzymes were high; patient only had arm pain; headache; After 2 hours of not feeling well; treated for a migraine; had a hard time swallowing,; had chest pain/felt like she was having a heart attack; her blood pressure was high.; also has tingling in her feet; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC ENZYME INCREASED (liver enzymes were high), VACCINATION SITE PAIN (patient only had arm pain), HEADACHE (headache), MALAISE (After 2 hours of not feeling well) and MIGRAINE (treated for a migraine) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PROPRANOLOL, FAMOTIDINE (PEPCID AC) and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEPATIC ENZYME INCREASED (liver enzymes were high), VACCINATION SITE PAIN (patient only had arm pain), HEADACHE (headache), MALAISE (After 2 hours of not feeling well), MIGRAINE (treated for a migraine), DYSPHAGIA (had a hard time swallowing,), CHEST PAIN (had chest pain/felt like she was having a heart attack), HYPERTENSION (her blood pressure was high.) and PARAESTHESIA (also has tingling in her feet). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) at a dose of 1 dosage form and LOSARTAN at a dose of 1 dosage form. At the time of the report, HEPATIC ENZYME INCREASED (liver enzymes were high), VACCINATION SITE PAIN (patient only had arm pain), HEADACHE (headache), MALAISE (After 2 hours of not feeling well), MIGRAINE (treated for a migraine), DYSPHAGIA (had a hard time swallowing,), CHEST PAIN (had chest pain/felt like she was having a heart attack), HYPERTENSION (her blood pressure was high.) and PARAESTHESIA (also has tingling in her feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-103805 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Migraine, Paraesthesia, Vaccination site pain
Clinical narrative: liver enzymes were high; patient only had arm pain; headache; After 2 hours of not feeling well; treated for a migraine; had a hard time swallowing,; had chest pain/felt like she was having a heart attack; her blood pressure was high.; also has tingling in her feet; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC ENZYME INCREASED (liver enzymes were high), VACCINATION SITE PAIN (patient only had arm pain), HEADACHE (headache), MALAISE (After 2 hours of not feeling well) and MIGRAINE (treated for a migraine) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PROPRANOLOL, FAMOTIDINE (PEPCID AC) and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEPATIC ENZYME INCREASED (liver enzymes were high), VACCINATION SITE PAIN (patient only had arm pain), HEADACHE (headache), MALAISE (After 2 hours of not feeling well), MIGRAINE (treated for a migraine), DYSPHAGIA (had a hard time swallowing,), CHEST PAIN (had chest pain/felt like she was having a heart attack), HYPERTENSION (her blood pressure was high.) and PARAESTHESIA (also has tingling in her feet). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) at a dose of 1 dosage form and LOSARTAN at a dose of 1 dosage form. At the time of the report, HEPATIC ENZYME INCREASED (liver enzymes were high), VACCINATION SITE PAIN (patient only had arm pain), HEADACHE (headache), MALAISE (After 2 hours of not feeling well), MIGRAINE (treated for a migraine), DYSPHAGIA (had a hard time swallowing,), CHEST PAIN (had chest pain/felt like she was having a heart attack), HYPERTENSION (her blood pressure was high.) and PARAESTHESIA (also has tingling in her feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-103805 (Patient Link).